Increased apoptosis accompanies neoplastic development in the human colorectum

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 1999-2006

  Sinicrope, Frank A ^a   Roddey, Gardiner ^a   McDonnell, Timothy J ^a   Shen, Yu ^a   Cleary, Karen R ^a   Stephens, L Clifton ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLON ADENOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NICK END LABELING; PRIORITY JOURNAL; TUMOR GROWTH;

APOPTOSIS; CELL DIVISION; COLORECTAL NEOPLASMS; HUMANS; IN SITU NICK-END LABELING; INTESTINAL MUCOSA; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030458010     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
2. Wyllie, A. H. The biology of cell death in tumours. Anticancer Res., 5: 131-136, 1985.
3. Haake, A. R., and Polakowska, R. R. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol., 101: 107-112, 1993.
4. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
5. Colombel, M., Olsson, C. A., Ng, P-Y., and Buttyan, R. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52: 4313-4319, 1992.
6. Celis, J. E., and Celis, A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc. Natl. Acad. Sci. USA, 82: 3262-3266, 1985.
7. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994
8. Sinicrope, F. A., Ruan, S., Cleary, K. R., Stephens, L. C., Lee, J. J., and Levin, B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55: 237-241, 1995.
9. Hague, A., Moorghren, M., Hicks, D., Chapman, M., and Paraskeva, C bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9: 3367-3370, 1994.
10. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
11. Ohue, M., Tomita, N., Mouden, T., Fujita, M., Fukunaga, M., Takami, K., Yana, I., Ohnishi, T., Enomoto, T., Inoue, M., Shimano, T., and Mori, T. A frequent alteration of the p53 gene in carcinoma and adenoma of the colon. Cancer Res., 54: 4798-4804, 1994.
12. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
13. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L , Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
14. Sinicrope, F. A., Hart, J., Michelassi, F., and Lee, J. J. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin. Cancer Res., 1: 1103-1110, 1995.
15. Risio, M., Lipkin, M., Candelaresi, G., Bertone, A., Coverlizza, S., and Rossini, F. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of familial neoplasia of the large bowel. Cancer Res., 51: 1917-1921, 1991.
16. Hall, P. A., Coates, P. J., Ansari, B., and Hopwood, D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell Sci., 107, 3569-3577, 1994.
17. Risio, M., Coverlizza, S., Ferrari, A., Candelaresi, G. L., and and Rossini, F. P. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology, 94: 899-906, 1988.
18. Terpstra, O. T., van Blankenstein, M., Dees, J., and Eilers, G. A. M. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology, 92: 704-708, 1987.
19. Hockenbery, D. M., Zutter, M., Hickley, W., Nahm, M., and Korsmeyer, S. J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
20. Baretton, G. B., Diebold, J., Christoforis, G., Vogt, M., Müller, C., Dopfer, K., Schneiderbanger, K., Schmidt, M., and Lohrs, U. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas: aspects of carcinogenesis and prognostic significance. Cancer (Phila.), 77: 255-264, 1996.
21. Baas, I. O., Mulder, J. R., Offerhaus, G. J. A., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
22. Auvinen, A., Isola, J., Visakorpi, T., Koivula, T., Virtanen, S., and Hakama, M. Overexpression of p53 and long term survival in colon carcinoma. Br J. Cancer, 70: 293-296, 1994.
23. Schulze-Osthoff, K., Wakzcak, H., Droge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol., 127: 15-20, 1994.
24. Ansari, B., Coates, P. J., Greenstein, B. D., and Hall, P. A. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol., 770: 1-8, 1993.
25. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. Determination of the length of histological changes of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (Lond.), 5: 847-853, 1990.
26. Strater, J., Koretz, K., Gunthert, A. R., and Moller, P. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut, 37: 819-825, 1995.
27. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
28. Bates, R. C., Buret, A., van Helden, D. F., Horton, M. A., and Burns, G. F. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol., 125: 403-415, 1994.
29. Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M., and Moorghren, M. TFG-β expression in human colon: differential immunostaining along the crypt epithelium. Br. J. Cancer, 68: 137-139, 1993.
30. Berges, R R., Vukanovic, J., Epstein, J. I., CarMichel, M., Cisek, L., Johnson, D. E., Veltri, D. W., Walsh, P. C., and Isaacs, J. T. Implications of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res., 1: 473-480, 1995.
31. Columbano, A., Ledda-Columbano, G. M., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: a sequential study. Am. J. Pathol., 116: 441-446, 1984
32. Isacson, C., Kessis, T. D., Hedrick, L., and Cho, K. R. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res., 56: 669-674, 1996.
33. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
34. 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology, 110: 1776-1784, 1996.
35. Potten, C. S. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev., 11: 179-195, 1992.
36. Leoncini, L., Del Vecchio, M. T., Megha, T., Barbini, P., Galieni, P., Pileri, S., Sabattini, E., Gherlinzoni, F., Tosi, P., Kraft, R., and Cottier, H. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol., 142: 755-763, 1993.
37. Kong, J., and Ringer, D. P. Immunohistochemical assessment of cell proliferation and death levels in well and poorly differentiated rat liver tumors. Proc. Am. Assoc. Cancer Res., 36: 230, 1995.
38. Kastrinakis, W. V., Ramchurren, N., Rieger, K. M., Hess, D. T., Loda, M., Steele, G., and Summerhayes, I. C. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene, 11: 647-652, 1995.
39. Lowe, S. W., Bodis, S., McClatchey, A , Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E , and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
40. Bardeesy, N., Beckwith, J. B., and Pelletier, J. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res., 55: 215-219, 1995